V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626909 | 330006786 | EEI00 | 1 | null | 1 | 2017-10-03 | NOT CHEMO | 330004796 | 330003544 | 330006787 |
| 16626910 | 330006786 | EEI00 | 1.4 | X721 | 2 | 2017-10-17 | CISPLATIN | 330004796 | 330003544 | 330006787 |
| 16626911 | 330006786 | ECL01 | 1000 | X724 | 1 | 2017-10-17 | MESNA | 330004796 | 330003544 | 330006787 |
| 16626912 | 330006786 | EEI00 | 2 | X724 | 1 | 2017-10-17 | NOT CHEMO | 330004796 | 330003544 | 330006787 |
| 16626913 | 330006786 | EPH | 8 | X722 | 5 | 2017-10-17 | DAUNORUBICIN | 330004796 | 330003544 | 330006787 |
| 16626914 | 330006787 | EEI00 | 1650 | null | 1 | 2015-02-01 | STEROID | 330004796 | 330003546 | 330006788 |
| 16626915 | 330006787 | EEI00 | 130 | null | 1 | 2015-02-02 | TRIAL | 330004796 | 330003546 | 330006788 |
| 16626916 | 330006788 | ECL02 | 64 | X292 | 5 | 2016-07-29 | NIVOLUMAB | 330004842 | 330007902 | 330006789 |
| 16626917 | 330006788 | EEI00 | 180 | X729 | 1 | 2016-07-29 | CYTARABINE | 330004842 | 330007902 | 330006789 |
| 16626918 | 330006788 | ECL01 | 40 | X724 | 1 | 2016-07-29 | NOT CHEMO | 330004842 | 330007902 | 330006789 |
| 16626919 | 330006788 | EEI00 | 2320 | null | 1 | 2016-07-29 | CYTARABINE | 330004842 | 330007902 | 330006789 |
| 16626920 | 330006788 | ECL02 | 120 | X721 | 1 | 2016-07-29 | CYTARABINE | 330004842 | 330007902 | 330006789 |
| 16626921 | 330006789 | EOI | 170 | null | 1 | 2015-04-03 | CISPLATIN | 330004842 | 330007902 | 330006790 |
| 16626922 | 330006789 | EUZ | 3040 | null | 2 | 2015-04-03 | PEMBROLIZUMAB | 330004842 | 330007902 | 330006790 |
| 16626923 | 330006789 | ELW | 10 | null | 1 | 2015-04-03 | TRIAL | 330004842 | 330007902 | 330006790 |
| 16626924 | 330006790 | EEI00 | 300 | null | 1 | 2013-09-22 | STEROID | 330004950 | 330003549 | 330006791 |
| 16626925 | 330006791 | EE813 | 0 | null | 1 | 2014-12-20 | IFOSFAMIDE | 330004950 | 330003549 | 330006792 |
| 16626926 | 330006791 | ECL01 | 3000 | X729 | 1 | 2014-12-21 | CYCLOPHOSPHAMIDE | 330004950 | 330003549 | 330006792 |
| 16626927 | 330006791 | EEI00 | 3100 | X292 | 1 | 2014-12-21 | MESNA | 330004950 | 330003549 | 330006792 |
| 16626928 | 330006791 | EPH | 0.5 | X724 | 1 | 2014-12-21 | NOT CHEMO | 330004950 | 330003549 | 330006792 |
| 16626929 | 330006791 | EE813 | 10 | X729 | 1 | 2014-12-22 | NOT CHEMO | 330004950 | 330003549 | 330006792 |
| 16626930 | 330006791 | EEI00 | 2 | X724 | 1 | 2014-12-23 | IFOSFAMIDE | 330004950 | 330003549 | 330006792 |
| 16626931 | 330006791 | EX950 | 1500 | X724 | 1 | 2014-12-23 | FLUOROURACIL | 330004950 | 330003549 | 330006792 |
| 16626932 | 330006791 | EAF01 | 1400 | X721 | 1 | 2014-12-24 | FLUOROURACIL | 330004950 | 330003549 | 330006792 |
| 16626933 | 330006791 | EOI | 5000 | X724 | 1 | 2014-12-24 | FLUOROURACIL | 330004950 | 330003549 | 330006792 |
| 16626939 | 330006794 | E1UZ0 | 2400 | null | 1 | 2013-11-16 | NOT CHEMO | 330004962 | 330003551 | 330006795 |
| 16626940 | 330006795 | EEI00 | 140 | X729 | 1 | 2017-06-18 | STEROID | 330004963 | 330007905 | 330006796 |
| 16626941 | 330006796 | EPH | 630 | x724 | 1 | 2017-01-03 | NOT CHEMO | 330004971 | 330003553 | 330006797 |
| 16626942 | 330006797 | EEI00 | 100 | null | 1 | 2017-11-16 | CETUXIMAB | 330004974 | 330003554 | 330006798 |
| 16626943 | 330006797 | EEI00 | 4 | X721 | 1 | 2017-11-17 | CYTARABINE | 330004974 | 330003554 | 330006798 |
| 16626944 | 330006797 | EEI00 | 40 | null | 2 | 2017-11-18 | NIVOLUMAB | 330004974 | 330003554 | 330006798 |
| 16626945 | 330006799 | EPH | 1.3 | null | 1 | 2016-05-20 | NOT CHEMO | 330005004 | 330003557 | 330006800 |
| 16626946 | 330006800 | EPH | 1200 | null | 1 | 2016-06-08 | NOT CHEMO | 330005014 | 330003559 | 330006801 |
| 16626947 | 330006800 | EEI00 | null | X729 | 1 | 2016-06-08 | CYCLOPHOSPHAMIDE | 330005014 | 330003559 | 330006801 |
| 16626948 | 330006800 | EEI00 | 814.5 | null | 1 | 2016-06-08 | TRIAL | 330005014 | 330003559 | 330006801 |
| 16626949 | 330006801 | ELW | 170 | null | 1 | 2017-10-09 | CYCLOPHOSPHAMIDE | 330005014 | 330003559 | 330006802 |
| 16626950 | 330006802 | EK1EN | 100 | null | 9 | 2016-08-20 | IFOSFAMIDE | 330005054 | 330003560 | 330006803 |
| 16626951 | 330006802 | E1UZ0 | 160 | X728 | 1 | 2016-08-27 | NOT CHEMO | 330005054 | 330003560 | 330006803 |
| 16626952 | 330006802 | EEI00 | 2040 | null | 5 | 2016-08-30 | RITUXIMAB | 330005054 | 330003560 | 330006803 |
| 16626953 | 330006804 | EUJ01 | 2 | null | 1 | 2016-04-16 | NOT CHEMO | 330005070 | 330010301 | 330006805 |
| 16626954 | 330006804 | EK1PP | 160 | X721 | 1 | 2016-04-17 | AZD9150 | 330005070 | 330010301 | 330006805 |
| 16626955 | 330006804 | EGU08 | 2040 | null | 1 | 2016-04-17 | RITUXIMAB | 330005070 | 330010301 | 330006805 |
| 16626956 | 330006806 | ED301 | 0 | null | 6 | null | VINCRISTINE | 330005070 | 330010301 | 330006807 |
| 16626957 | 330006806 | EOF | 190 | null | 1 | null | NOT CHEMO | 330005070 | 330010301 | 330006807 |
| 16626958 | 330006807 | EOI | 2 | null | 2 | 2018-02-15 | VINCRISTINE | 330005070 | 330010301 | 330006808 |
| 16626959 | 330006807 | EEI00 | 1650 | X721 | 1 | 2018-03-05 | CISPLATIN | 330005070 | 330010301 | 330006808 |
| 16626960 | 330006807 | EEI00 | 814.5 | null | 1 | 2018-03-08 | CYTARABINE | 330005070 | 330010301 | 330006808 |
| 16626961 | 330006807 | EKA | 0 | null | 2 | 2018-03-08 | CYCLOPHOSPHAMIDE | 330005070 | 330010301 | 330006808 |
| 16626962 | 330006807 | EPH | 180 | null | 1 | 2018-03-09 | VINCRISTINE | 330005070 | 330010301 | 330006808 |
| 16626963 | 330006807 | EEI00 | 0 | X729 | 1 | 2018-03-10 | IFOSFAMIDE | 330005070 | 330010301 | 330006808 |